1-20 of 34
drug class effects
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

Marius E Mayerhoefer, Alexander Haug, Ulrich Jaeger, MD, Lukas Kazianka, MD, Verena Pichler, Sarah Pfaff, Hans-Jürgen Wester, PhD, Marcus Hacker, Philipp Bernhard Staber, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1750.
https://doi.org/10.1182/blood-2019-131469
Published: 2019
Journal Articles

Evaluation of a Next-Generation FVIII Mimetic Antibody, Mim8, in Combination with Recombinant FVIIa, FVIII and Activated Prothrombin Complex Concentrate

Laurent Burnier, PhD, Mette B Hermit, PhD, Ida Hilden, Mirella Ezban, PhD, Stine L Kjellev, PhDDVM
Journal: Blood
Blood (2019) 134 (Supplement_1): 2388.
https://doi.org/10.1182/blood-2019-123340
Published: 2019
Journal Articles

Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies

Julie Kanter, MD, Darla K Liles, MD, Kim Smith-Whitley, MD, Clark Brown, MD PhD, Abdullah Kutlar, MD, Brian Elliott, Amit Shah, Jeremie Lincy, Susan Poggio, Kenneth I. Ataga, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 991.
https://doi.org/10.1182/blood-2019-123965
Published: 2019
Journal Articles

RBC-Specific CD47 Pruning Confers Protection and Underlies the Transient Anemia in Patients Treated with Anti-CD47 Antibody 5F9

James Y Chen, MD PhD, Kelly Marie McKenna, BS, Timothy S Choi, BS, Jiaqi Duan, MS, Lynette Brown, MSc, Jennifer J Stewart, PhD, Kavitha Sompalli, MS, Paresh Vyas, Stanley Schrier, MD, Ravindra Majeti, MD PhD, Irving L Weissman, MD, Kyle Elrod, BS, Mark Ping Chao, MD PhD, Chris H Takimoto, MD PhD, Jie Liu, PhD MD, Jens-Peter Volkmer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2327.
https://doi.org/10.1182/blood-2018-99-115674
Published: 2018
Journal Articles

Azacitidine and Romidepsin Synergize to Induce Expression of Cancer Testes Antigens (CTA) and Shift Peripheral T-Cell Lymphoma (PTCL) Cell Lines Toward a Th1-like Phenotype

Cristina Kinahan, BS, Luigi Scotto, PhD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2845.
https://doi.org/10.1182/blood-2018-99-117344
Published: 2018
Journal Articles

Interest of Dosing of Ibrutinib in B-Cell Lymphoid Malignancies: Data from a Real-Life, Phase 4 Study

Anne Calleja, Sandra De Barros, Camille Vinson, PharmD, Caroline Protin, MD, Lucie Oberic, MD, Fanny Gallais, Melanie White-koning, Etienne Chatelut, Christian Recher, MD PhD, Sarah Cadot, PhD, Anne Quillet Mary, PhD, Loic Ysebaert, MD PhD, Fabien Despas, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3960.
https://doi.org/10.1182/blood-2018-99-116532
Published: 2018
Journal Articles

Direct Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism: A Systematic Review & Network Meta-Analysis

Mia Djulbegovic, MD, Alfred Lee, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4721.
https://doi.org/10.1182/blood.V130.Suppl_1.4721.4721
Published: 2017
Journal Articles

Upregulation of CD38 Expression on Multiple Myeloma Cells By the HDAC Inhibitor Ricolinostat Augments the Efficacy of Daratumumab

Estefania Garcia-Guerrero, Sophia Danhof, Martin Schreder, MD, José A. Pérez-Simón, Hermann Einsele, Michael Hudecek
Journal: Blood
Blood (2017) 130 (Supplement 1): 1803.
https://doi.org/10.1182/blood.V130.Suppl_1.1803.1803
Published: 2017
Journal Articles

MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs

Athalia Rachel Pyzer, MD, Dina Stroopinsky, PhD, Jacalyn Rosenblatt, MD, Eleni Anastasiadou, PhD, Hasan Rajabi, PhD, Abigail J. Washington, BA, Ashujit Tagde, PhD BPharm, Maxwell Douglas Coll, Leandra Cole, BA, Kristen Anna Palmer, Poorvi Somaiya, Rebecca Karp Leaf, MD, Myrna R. Nahas, MD, Arie Apel, MD, Salvia Jain, MD, Robin Joyce, MD, Jon Arnason, MD, Frank Slack, PhD, Donald Küfe, MD, David E. Avigan, MD
Journal: Blood
Blood (2016) 128 (22): 2871.
https://doi.org/10.1182/blood.V128.22.2871.2871
Published: 2016
Journal Articles

A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma: Canadian Cancer Trials Group Study LY.15

Tony Reiman, MD, Kerry J. Savage, MD MSc, Michael Crump, MD, Matthew Cheung, MD, David A. MacDonald, MD, Rena Buckstein, MD, Stephen Couban, MD, Eugenia Piliotis, MD, Kevin R Imrie, MD, David Spaner, MD PhD, Sudeep Shivakumar, MD, John Kuruvilla, MD, Diego Villa, Lois E. Shepherd, MD, Tanya Skamene, MD, Chad Winch, Bingshu E Chen, PhD, Annette E Hay, MB ChB
Journal: Blood
Blood (2016) 128 (22): 4162.
https://doi.org/10.1182/blood.V128.22.4162.4162
Published: 2016
Journal Articles

MYC-Dependent PI3K and MCL-1 Feedbacks Attenuate BET Inhibitors Activity in Diffuse Large B-Cell Lymphoma

Enrico Derenzini, MD PhD, Patrizia Mondello, MD MSc, Yuxuan Liu, PhD, Mary Scallion, Zahra Asgari, John Philip, Patrick Hilden, MS, Hakim Djaballah, PhD, Ouathek Ouerfelli, PhD, Elisa de Stanchina, PhD, Venkatraman Seshan, PhD, Ronald Hendrickson, PhD, Andrew D. Zelenetz, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 294.
https://doi.org/10.1182/blood.V128.22.294.294
Published: 2016
Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD
Journal: Blood
Blood (2016) 128 (22): 5429.
https://doi.org/10.1182/blood.V128.22.5429.5429
Published: 2016
Journal Articles

Comprehensive Quantitative Proteomic Profiling of the Pharmacodynamic Changes Induced By MLN4924 in Acute Myeloid Leukemia Cells Reveals Rational Targets for Combination Therapy

Valeria Visconte, PhD, Steffan T. Nawrocki, PhD, Kevin R. Kelly, MD PhD, Yingchun Han, MD, Anthony Possemato, Sean Beausoleil, Aziz Nazha, MD, Jaroslaw P. Maciejewski, MD PhD, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Mikkael A. Sekeres, MD MS, Jennifer S. Carew, PhD
Journal: Blood
Blood (2015) 126 (23): 1271.
https://doi.org/10.1182/blood.V126.23.1271.1271
Published: 2015
Journal Articles

The Class Effect of Tyrosine Kinase Inhibiotrs on Impaired Platelet Aggregation on Stimulation with Collagen and Arachidonic Acid

Warit Wangsuekul, MD, Lalita Norasetthada, MD, Adisak Tantiworawit, MD, Ekarat Rattarittamrong, MD, Chatree Chai-Adisaksopha, MD, Sasinee Hantrakool, MD, Thanawat Rattanathammethee, MD
Journal: Blood
Blood (2015) 126 (23): 5172.
https://doi.org/10.1182/blood.V126.23.5172.5172
Published: 2015
Journal Articles

IMGN529, a Novel Antibody-Drug Conjugate (ADC) Targeting CD37 Shows Synergistic Activity with Rituximab in Non-Hodgkin Lymphoma (NHL) Models

Jutta Deckert, PhD, Callum M Sloss, PhD, Katie O'Callaghan, PhD, Jenny Tsui, BS, Nemisha Dawra, BS, Yong Yi, MD, Jennifer A Coccia, BS, Leanne Lanieri, BS, Sharon Chicklas, BS, Angela Romanelli, PhD
Journal: Blood
Blood (2015) 126 (23): 1548.
https://doi.org/10.1182/blood.V126.23.1548.1548
Published: 2015
Journal Articles

Pathway-Directed High Throughput Drug Screen Identifies PI3K Inhibitors That Synergistically Potentiate Anti-Tumor Activity of HDAC Inhibitors in Mycosis Fungoides and Sezary Syndrome

Weiyun Ai, MD PhD, Chen-Yen Yang, PhD, Razan Faraj, Taha Rakhshandhroo, BSc, Shervin Afghani, BSc, Laura Pincus, MD, Sourav Bandyopadhyay, PhD, Frank McCormick, PhD FRS
Journal: Blood
Blood (2015) 126 (23): 2755.
https://doi.org/10.1182/blood.V126.23.2755.2755
Published: 2015
Journal Articles

Reversal of Novel Oral Anticoagulant (NOAC)-Induced Bleeding in Mice By Engineered super factor Va

Vikas Bhat, PhD, Andrew J. Gale, PhD, John H. Griffin, PhD, Laurent O. Mosnier, PhD, Annette von Drygalski, MD PharmD
Journal: Blood
Blood (2014) 124 (21): 695.
https://doi.org/10.1182/blood.V124.21.695.695
Published: 2014
Journal Articles

Sodium Salicylate Has a Priming Effect When Combined with Azacitidine in Pre-Clinical Models of AML

Yehuda E. Deutsch, MD, Aymee Perez, PhD, Ana Rodrigues, BS, Ezra S. Blumenthal, Elena Cubedo, PhD, Justin M. Watts, MD, Ronan T Swords, MD PhD FRCPI, FRCPath, Arthur Zelent, PhD
Journal: Blood
Blood (2014) 124 (21): 2300.
https://doi.org/10.1182/blood.V124.21.2300.2300
Published: 2014
Journal Articles

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Vania T M Hungria, MDPhD, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, MD, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L. Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, Sagar Lonial, MD, Jae Hoon Lee, MD PhD, Hermann Einsele, Hans Salwender, MD, Monika Sopala, Ashok Panneerselvam, Suman Redhu, Claudia Corrado, Florence Binlich, Jesus F. San Miguel
Journal: Blood
Blood (2014) 124 (21): 2120.
https://doi.org/10.1182/blood.V124.21.2120.2120
Published: 2014
Journal Articles

Cell Non-Autonomous Modulation Of Tumor Cell Responses To Pharmacological Inhibition Of The Proteasome

Eugen Dhimolea, PhD, Richard W.J. Groen, PhD, Catriona A. Hayes, MD, Jana Jakubikova, PhD, Bariteau Megan, Jake E. Delmore, Hannah M. Jacobs, Julio-Cesar Marin, Gregory Della Penna, Douglas W. McMillin, PhD, Ana Acuna, Panisinee Lawasut, MD, Nancy Kohl, PhD, Constantine S. Mitsiades, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4454.
https://doi.org/10.1182/blood.V122.21.4454.4454
Published: 2013